Cagri Yildirim-Toruner, MD, Betty Diamond, MD 

Slides:



Advertisements
Similar presentations
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Advertisements

D-dimer: A biomarker for antihistamine-resistant chronic urticaria
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
What drives prescription patterns in pediatric asthma management?
Monoclonal antibodies and fusion proteins in medicine
Allergen immunotherapy: A practice parameter third update
Pharmacologic rationale for treating allergic and nonallergic rhinitis
Fatty acids, inflammation, and asthma
Advances in food allergy in 2015
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Major rabbit allergen Ory c 3: What could be its possible role as a sensitizing agent in real life?  Gennaro Liccardi, MD, Antonello Salzillo, MD, Maria.
David A. Khan, MD  Journal of Allergy and Clinical Immunology 
Is 9 more than 2 also in allergic airway inflammation?
Desensitization to Chemotherapeutic Agents
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Fatty acids, inflammation, and asthma
Allergic skin diseases
An Infant with Atopic Dermatitis and Itching After Ingestion of Milk
Zuhair K. Ballas, MD  Journal of Allergy and Clinical Immunology 
Etienne C. E. Wang, MBBS, PhD, Zhenpeng Dai, PhD, Angela M
David J. Cousins, PhD, Joanne McDonald, BSc, Tak H. Lee, MD, ScD 
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
The National Biome Initiative: An allergy perspective
Nonadherence to Asthma Treatment: Getting Unstuck
Peter M. Wolfgram, MD, David B. Allen, MD 
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Phillip Lieberman, MD, Michael Tankersley, MD 
A survivor: The eosinophil as a regulator in asthma
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
News & Notes Journal of Allergy and Clinical Immunology
Phillip Lieberman, MD, David Golden, MD 
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Claus Bachert, MD, PhD, Cezmi A. Akdis, MD 
Update on the role of prostaglandins in allergic lung inflammation: Separating friends from foes, harder than you might think  Martin L. Moore, PhD, R.
Effect of ingested H1 antihistamines on methacholine challenge
What is an “eosinophilic phenotype” of asthma?
Cephalosporin Side Chain Cross-reactivity
H. William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Role of regulatory T cells and FOXP3 in human diseases
Personalized asthma therapy in blacks—the role of genetic ancestry
Autophagy: Nobel Prize 2016 and allergy and asthma research
IL-2– and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets  Sven Létourneau, DPhil, Carsten Krieg, PhD, Giuseppe Pantaleo,
News & Notes Journal of Allergy and Clinical Immunology
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Advances in the approach to the patient with food allergy
Clinical consequences of defects in B-cell development
New pathways for itching in patients with atopic dermatitis?
Prevention of food allergy: Beyond peanut
One step forward, 2 steps back: The enigma of preschool wheeze
Benjamin Chaigne, MD, Hervé Watier, MD, PhD 
Eosinophilic esophagitis treated with immunotherapy to dust mites
Advances in basic and clinical immunology in 2013
Measles and immunomodulation
Stefan Schülke, PhD, Stefan Vieths, PhD 
The Editors' Choice Journal of Allergy and Clinical Immunology
Macrolide antibiotics and asthma treatment
Immune pathomechanism of drug hypersensitivity reactions
Asthma: The past, future, environment, and costs
Albert Y. Wu, MD, Sanjiv Sur, MD, J. Andrew Grant, MD 
Environmental factors and eosinophilic esophagitis
Kinase inhibitors in clinical practice: An expanding world
News & Notes Journal of Allergy and Clinical Immunology
Monoclonal antibodies and fusion proteins and their complications: Targeting B cells in autoimmune diseases  Susan Lee, MD, Mark Ballow, MD  Journal of.
Advances in pediatric asthma in 2007
Natural history of cow’s milk allergy
Susan L. Janson, DNSc, Kelly Wong McGrath, BA, Jack K
Primary prevention of asthma and allergy
Itching as a systemic disease
Presentation transcript:

Current and novel therapeutics in the treatment of systemic lupus erythematosus  Cagri Yildirim-Toruner, MD, Betty Diamond, MD  Journal of Allergy and Clinical Immunology  Volume 127, Issue 2, Pages 303-312 (February 2011) DOI: 10.1016/j.jaci.2010.12.1087 Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 B cell costimulatory molecules and receptors for the survival factors BAFF and APRIL are shown as well as cell surface molecules being targeted therapeutically. The therapeutic agents are identified along with their targets. BCMA, B-cell maturation antigen; CTLA-4, Cytotoxic T lymphocyte–associated antigen 4. Journal of Allergy and Clinical Immunology 2011 127, 303-312DOI: (10.1016/j.jaci.2010.12.1087) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions